ABSTRACT BACKGROUND: In our present study, we aimed to evaluate the effects of taurolidine, a blocking agent of fibrin deposition, and icodextrin, a colloid osmotic material that also inhibits fibrin accumulation, and the effect of their application separately and concomittantly in intra-abdominal adhesion prevention.
site. The rate of intra-abdominal adhesion formation following abdominal surgeries is 67%-93%. [1] Postoperative intraabdominal adhesions still remain as major obstacle in successful treatment of patients with acute mechanical intestinal obstruction. [2, 3] Nearly 75% of these cases suffer from signs and symptoms of ileus. Our records describe a rate of 45.5%. [4] Other consequences of intra-abdominal adhesions are as infertility, chronic pelvic pain, and major additive complications of secondary surgeries. [5] Postoperative intra-abdominal adhesions may cause a significant increase in hospital costs because of high morbidity and mortality rates. [3] Depending on the severity of the obstruction, a partial obstruction may relieve itself with a conservative approach. However, many adhesions require surgery for treatment. Therefore, various efforts have been made to overcome adverse effects of adhesions. Meticulous dissection of tissues to avoid surgical trauma, manipulation of time-consuming effect of ischemia time, absence of overheated liquids while washing the intestines, providing ideal surgical manipulation by appropriate use of devices such as ecarteurs or cautery have all limited impacts in adhesion prevention. Various agents, including pharmacological drugs and physical barriers, were administered to avoid
INTRODUCTION
Adhesions form as a natural part of the body's healing process after surgery in a similar manner as scars. The term adhesion is commonly used when the scar extends from within one tissue across another tissue, usually across the peritoneal cavity in surgical cases. Postsurgical adhesions commonly occur when two separate surfaces are close to one another. This type of formation may cause inflammation and accumulation of fibrin deposits on damaged tissues. Fibrin then connects two separate tissues and acts like a glue to seal the injured adhesions. Taurolidine is an antimicrobial agent used to prevent intra-abdominal adhesion formation and sepsis in experimental and clinical trials. In previous studies, the blocking effects of taurolidine on fibrin deposition have been described. [6] Icodextrin is an colloid osmotic material used in forming an aqueous solution for peritoneal dialysis and after gynecological procedures for reducing postoperative adhesions. The osmotic activity of icodextrin helps in separating tissues and reducing adhesive effects of fibrin. Tissues are kept from gluing together. In our present study, we aimed to evaluate effects of taurolidine and icodextrin in preventing intra-abdominal adhesions separately and to determine whether they have a synergistic effect when used concomitantly.
MATERIALS AND METHODS
This present study was conducted at Pendik Veterinary Control and Research Institute Experimental Animals Unit. Our study was approved by the Pendik Veterinary Control and Research Institute Animal Experiments Local Ethics Committee (25/17) . Forty BALB/c male mice, weighing 30-35 g and 11-12 weeks old, were bred in Pendik Veterinary Control and Research Institute. The animals were randomized into four groups, consisting of 10 rats as follows: group 1: control group, group 2: taurolidine group, group 3: icodextrin group, and group 4: taurolidine and icodextrin group. Animals were kept in eight cages (five mice in each) with satisfactory environment conditions and room temperatur e in 12 h day/night cycles with free access to water and specific pathogen-free conditions. All animals were fed a normal diet.
Surgical Technique
All surgical procedures and approaches have been performed in semi-sterile environment. All animals were anesthetized with 4 mg/kg xylazine (Rompun, Bayer Turk Kimya San. Ltd. Sti., Istanbul, Turkey) and 100 mg/kg ketamine hydrocloride (Ketasol, Richter Pharma Ag, Wels, Austria) via the intramuscular route. Spontaneous breathing of mice has been provided perioperatively and with the help of a table lamp, the body temperature was maintained at 37°C. Prior to the incision, the abdominal space of all animals were cleaned and wiped with povidone iodide. Laparotomy was performed with a 15-mm midline incision. Two animals died because of adverse effects of anesthesia, but they were replaced with animals of the same species and gender. Initially, to achieve intraperitoneal adhesion, a cecal abrasion model was formed in all groups. Thus, following a 15-mm midline incision, the cecum was found and a 1 cm 2 defect in the serous layer and an additional 1 cm 2 peritoneal damage was created on the abdominal wall using a lancet. The intestines of all animals were re-placed into the abdominal cavity. In group 1 (n=10), the abdomen was closed without any pharmacologic agent administration (the control group). In group 2 (n=10), 1 ml (0.02 g) taurolidine (Taurolin ® , Geistlich Sohns Ltd,Wolhusen, Switzerland) instillation was performed before closure (the taurolidine group). In group 3 (n=10), 1 ml (0.04 g) icodextrin 4% (Adept ® , Baxter Healthcare Corporation, Deerfield, USA) instillation was performed (the icodextrin group). Finally, in group 4 (n=10), the abdomen was closed following 0.5 ml (0.01 g) taurolidine and 0.5 ml (0.02 g) icodextrin 4% instillation (the taurolidine and icodextrin group).
All animals were kept for 14 days and sacrificed by cervical dislocation. The abdominal cavity was reopened with a reverse U-shaped incision. Adhesions were scored by two blind observers according to Nair's macroscopic adhesion staging system, which has been used and tested before. [7] Cecum and adherent organs were extracted for histopathological analysis. All specimens were fixed in 10% formalin solution for histopathological evaluation. According to routine tissue processing, serial sections (5 µm) were stained with hematoxylin and eosin. Histopathological evaluation of the adhesions was performed by a blind investigator, following the rules followed by Zühlke et al. [8] Statistical analysis was performed using the Statistical Package for Social Sciences software (SPSS Inc, vers. 13.0, Chicago, IL, USA). Numeric values were represented as n (number 
RESULTS
The adhesion scoring system defined by Nair et al was used in our study. Zero represents complete absence of adhesion, whereas 4 stands for viscera directly adherent to the abdominal wall. Table 1 describes the macroscopic scoring system. We tried to document our macroscopic findings in Figure 1 . Adhesive band formation scores for specific groups are shown in Table 3 ; there was a statistically significant difference between all groups on overall comparison (p=0.007).
No mice was detected with score 4 in group 2; scores 3 and 4 in group 3; scores 2, 3, and 4 in group 4. There was a significant statistical difference between all the groups and the control group, whereas there was no statistical difference among the study groups (i.e., groups 2-4) ( Table 4 ).
According to Zühlke et al's histological classification system, 1 stands for loose connective tissue, whereas 4 represents old, firm granulation tissue. 
DISCUSSION
Postoperative intra-abdominal adhesion formation is a significant cause of morbidity and mortality and can also result in major technical difficulties during subsequent surgeries. During surgical procedures within the abdominal cavity, injury and ischemia of the peritoneum may result in adhesion formation. In response to trauma and ischemia, the damage on the peritoneum is usually covered with neutrophils in 4 h. Complete recovery takes place in nearly 1 week. [9] [10] [11] Though structurally different, the peritoneal recovery process is a biochemically inflammatory process and it is theoretically possible to manipulate this process using pharmacological agents, via their anti-inflammatory efficacy of resulting in increased fibrinolytic activity. In previous studies, non-steroidal anti-inflammatory drugs have been used, both perioperatively and postoperatively, for their anti-inflammatory effects on adhesion prevention. However, their impacts were insufficient and side effects remain as major obstacles in successful application. [12, 13] Also, corticosteroids have been administered for preventing adhesions considering their suppressive effects against inflammatory response but have been found to be insufficient with low doses and serious side effects have been found with high doses. [14, 15] Several pharmacological agents, such as high doses of vitamin E and simvastatin, were discovered to have a high efficacy in adhesion prevention. [16] [17] [18] Taurolidine is an antimicrobial agent used for intra-abdominal adhesion formation and sepsis prevention in experimental and clinical trials. In previous studies, the blocking effects of taurolidine on fibrin deposition have been described. [6] Taurolidine prevents long-term postoperative inflammation. [19] [20] [21] Tarhan et al. reported that intraperitoneal administration of taurolidine increases t-PA levels and t-PA plasminogen activator inhibitor type-1 ratio. This mechanism explains the effect of taurolidine on the peritoneal fibrinolytic system. [22] Taurolidine also have antiendotoxic, antibacterial, and tumoricidal effects besides its adhesion preventive effect. Its antimicrobial capacity against gram-positive, gram-negative, and anaerobic bacteria and some fungi makes taurolidine an effective drug. It can be used in infections with resistance against a wide range of antibiotics, such as staphylococcus resistant to metisiline and enterococcus resistant to vancomycine. [19, 23] In our study, taurolidine has been explored and evaluated for its adhesion preventive effects. A statistically significant adhesion preventive effect has been found compared with the control group. We believe that taurolidine can be utilized for abdominal adhesion prevention.
Apart from pharmacological agents, physical barriers are also successful as they keep damaged surfaces apart during inflammatory response. As concomitant repair of the peritoneum takes place through all damaged surfaces, the ideal physical barrier should keep all peritoneal surfaces apart at the same time and for the same time period. Hyaluronic acid-saline buffered with phosphate combination or hyaluronic acid- carboxymethyl cellulose membrane has prevented peritoneal adhesions in a multicenter clinical trial. [24, 25] Icodextrin is a colloid osmotic material used for forming an aqueous solution for peritoneal dialysis and after gynecological procedures for reducing postoperative adhesions. The osmotic activity of icodextrin helps in separating tissues and reducing adhesive effects of fibrin. Tissues are kept from gluing together. Icodextrin is a solution whose adhesion preventive effects have been proven in preclinical and clinical studies. [26] [27] [28] Its ability to keep both damaged and non-damaged peritoneal surfaces apart makes it an ideal physical barrier. Icodextrin (4%) solution is not absorbed from the peritoneal space for 48 h; only half of it is absorbed in 96 h; thus, it continues showing its efficacy through the peritoneal surface for 3-5 days, which is a critical period for adhesion formation. [29] Besides, icodextrin has no effect on wound healing. [27] In our study, we have used icodextrin 4% in group 3 animals. No adhesions of scores 3 and 4 have been detected. Compared with the control group, its adhesion preventive effect in group 3 has been found to be significant. We believe that anti-inflammatory effects and separation of damaged surfaces are required in combination for abdominal adhesion prevention. This synergistic impact can be achieved through the combined administration of taurolidine and icodextrin. Considering the features of these two different materials, we can predict that an ideal adhesion preventative material can be formed. Increased fibrinolytic activity and distance between peritoneal surfaces for a required period are the main goals of our study. Taurolidine and icodextrin, though having different mechanisms of activity, share similar usage patterns. In particular, their efficacy does not alter with respect to the implementer as they have easy application features. Although these two agents have not been recently discovered, concomitant application has not been observed in literature. In our study, we detected high abdominal adhesion preventive effects of taurolidine and icodextrin. The difference has been found to be statistically significant.
In our study, compared with groups 2 and 3, no experimental animal in group 4 had a score of 2, 3, and 4 for adhesion severity In addition, some animals in group 4 showed nearly normal serosal surfaces on evaluation of histopathological specimens. We believe that the combined application of taurolidine and icodextrin could be responsible for this synergistic effect. Our evaluation using Zuhlke's classification of histopathological tissues supported this idea.
Optimal dose of taurolidine and icodextrin in BALB/c species mice is not known; therefore, dose-dependent studies should be planned for future evaluations. Pharmacological agents, such as corticosteroids and vitamin E, has adhesion preventive effects at high doses. [14] [15] [16] [17] Future studies may show similar impacts of taurolidine and icodextrin. In literature, there is a study in which in 2 ml (0.04 g) of taurolidine 2% solution has been used as an adhesion preventative. [30] Results of that study were similar to our findings. They were not able to discover any dose-dependent effects.
Our current study is the first experimental design for determining the efficacy of icodextrin 4% solution in adhesion prevention. Our results revealed successful adhesion prevention using with 1 ml (0.04 g) icodextrin. Concomitant application of taurolidine and icodextrin 4% solution was also tested for the first time (0.5 ml). In light of this pioneer study, further evaluations for dose adjustment are required to overcome adverse effects of abdominal adhesions.
In conclusion, taurolidine and icodextrin, when used alone or together, decrease postoperative intra-abdominal adhesion formation. Macroscopic appearance was not supportive of statistical difference between taurolidine and icodextrin group and other groups. Microscopic evaluation paves the way for future studies as significant abdominal adhesion preventive effects were observed when taurolidine and icodextrin were applied concomitantly. Additional experimental studies are required for dose adjustment.
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